Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis

Figure 5

Enriched analysis of DEGs between high- and low-IGF2BP3 expression groups. (a) Biological processes, (b) cellular components, (c) molecular functions, and (d) KEGG pathways.

(a)

(b)

(c)

(d)